Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anas Alawawdeh

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Expert Review of Anticancer Therapy|November 9, 2020
Curative therapy for rectal cancerAnas Alawawdeh, Tharani Krishnan, Amitesh Roy, et al.
Asia-Pacific Journal of Clinical Oncology|November 23, 2021
Regorafenib outcomes from the population based South Australian Metastatic Colorectal Cancer RegistryAnas Alawawdeh, Timothy Price, Christos Karapetis, et al.
Targeted Oncology|November 25, 2021
Prognostic Differences of RAS Mutations: Results from the South Australian Metastatic Colorectal RegistryAnas Alawawdeh, Cynthia Piantadosi, Amanda Rose Townsend, et al.
British Journal of Cancer|March 27, 2025
A phase 1 study to assess the safety, tolerability and effectiveness of PV-10 (Rose Bengal Sodium) in neuroendocrine tumours metastatic to the liverTimothy Price, Laura Depauw, Gabrielle Cehic, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Expert Review of Anticancer Therapy|November 9, 2020
Curative therapy for rectal cancerAnas Alawawdeh, Tharani Krishnan, Amitesh Roy, et al.
Asia-Pacific Journal of Clinical Oncology|November 23, 2021
Regorafenib outcomes from the population based South Australian Metastatic Colorectal Cancer RegistryAnas Alawawdeh, Timothy Price, Christos Karapetis, et al.
Targeted Oncology|November 25, 2021
Prognostic Differences of RAS Mutations: Results from the South Australian Metastatic Colorectal RegistryAnas Alawawdeh, Cynthia Piantadosi, Amanda Rose Townsend, et al.
British Journal of Cancer|March 27, 2025
A phase 1 study to assess the safety, tolerability and effectiveness of PV-10 (Rose Bengal Sodium) in neuroendocrine tumours metastatic to the liverTimothy Price, Laura Depauw, Gabrielle Cehic, et al.
Pageof 1